Skip to content

308-nm excimer laser plus topical calcipotriol in the treatment of vitiligo

308-nm excimer laser plus topical calcipotriol in the treatment of vitiligo

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138808212704N1
Enrollment
70
Registered
2010-12-02
Start date
2007-05-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. Vitiligo

Interventions

Intervention 1: 308-nm excimer laser two times weekly for 12 weeks plus Calcipotriol ointment (Daivonex®) twice daily. Intervention 2: 308-nm excimer laser two times weekly for 12 week plus Vaseline t
Treatment - Drugs
Placebo
308-nm excimer laser two times weekly for 12 weeks plus Calcipotriol ointment (Daivonex®) twice daily
308-nm excimer laser two times weekly for 12 week plus Vaseline twice daily

Sponsors

Research department of medical school of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: The patients that suffer from localized or generalized vitiligo at least for one year or stable vitiligo, All the phenotypes of skin color. Exclusion criterion: Pregnancy, Lactation, Allergy to calcipotriol, Renalinsufficiency, Abnormality in bone or calcium metabolism, Light-sensitive dermatoses, Photodermatoses, Phototoxic systemic or topical medication, Previous history of arsenic exposure, Excessive exposure to UV light, Previous history of skin cancer.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Repigmentation. Timepoint: first visit,12 weeks after starting therapy. Method of measurement: Visual scale software.

Secondary

MeasureTime frame
Irritant contact dermatitis. Timepoint: 2 times per week(in each phototherapy session). Method of measurement: clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayeh Khezri

Razi Hospital

khezri@razi.tums.ac.ir+98 21 5560 9951

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026